Endometrial cancer is one of the most common gynecological malignancies, and while most cases are sporadic, genetics and family history can significantly influence an individual’s risk. Understanding these genetic links allows for earlier surveillance, timely intervention, and informed decision-making, rather than waiting for symptoms to appear.
Is Endometrial Cancer Inherited?
Endometrial cancer is not usually directly inherited, but certain inherited genetic mutations can markedly increase risk. The most important of these is Lynch syndrome, also known as hereditary non-polyposis colorectal cancer (HNPCC).
Lynch syndrome results from mutations in DNA mismatch repair (MMR) genes such as MLH1, MSH2, MSH6, and PMS2, leading to genomic instability and cancer development. Women with Lynch syndrome have a 40–60% lifetime risk of developing endometrial cancer, often at a younger age than the general population.
Role of Family History
A strong family history of:
- Endometrial cancer
- Colorectal cancer
- Ovarian or gastric cancer
especially in first-degree relatives, raises suspicion for hereditary cancer syndromes. Importantly, endometrial cancer may be the first cancer to appear in women with Lynch syndrome, preceding colorectal cancer.
Evidence from Clinical Studies
Studies show that up to 5% of endometrial cancers are linked to hereditary syndromes, with Lynch syndrome being the most common. These cancers often present earlier and may not be associated with traditional risk factors such as obesity or unopposed estrogen exposure.
Routine tumor testing for MMR deficiency or microsatellite instability (MSI) is now recommended in many guidelines to identify patients who may benefit from genetic counseling.
Genetic Testing and Screening
Genetic testing is advised for women who:
- Are diagnosed with endometrial cancer before age 50
- Have a strong family history of related cancers
- Show MMR deficiency on tumor testing
For high-risk individuals, proactive strategies include:
- Regular gynecological surveillance
- Early and personalized screening protocols
- Risk-reducing interventions when appropriate
Clinical and Public Health Relevance
Knowing one’s genetic risk empowers patients and clinicians to move from reactive care to preventive care. Genetic counseling and testing not only benefit the individual but also enable at-risk family members to seek timely evaluation.
Raising awareness that endometrial cancer can have a genetic basis is essential to ensure cancers are detected early—when outcomes are most favorable.
Reader question:
Should genetic risk assessment become a routine part of endometrial cancer care rather than an exception?
MBH/PS